ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report

ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report

English
3 Pages
Read
Download
Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report PR Newswire ALBANY, New York, July 13, 2012 ALBANY, New York, July 13, 2012 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media GBI Research, the leading business intelligence provider, has released its latest research, Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media, which provides insights into the up-and-coming trends of DTC advertising in the US and of awareness campaigns in Europe. The report provides an in-depth analysis of the types of marketing channels available to pharmaceutical marketers. In particular it focuses on how pharmaceutical marketers can make the most of digital media channels, including online advertising and social media. To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/direct-to-consumer-dtc-advertising- in-pharmaceuticals-shift-from-traditional-mass-media-platforms- towards-personalization-via-online-and-social-media-report.

Subjects

Informations

Published by
Reads 9
Language English
Report a problem
ResearchMoz.US: Direct to Consumer (DTC)
Advertising in Pharmaceuticals - Shift From
Traditional Mass-Media Platforms Towards
Personalization via Online and Social Media-
Market Research Report
PR Newswire
ALBANY, New York, July 13, 2012
ALBANY, New York
,
July 13, 2012
/PRNewswire/ --
New Report Added in ResearchMoz Reports Database Direct to
Consumer (DTC) Advertising in Pharmaceuticals - Shift from
Traditional Mass-Media Platforms towards Personalization via Online
and Social Media
GBI Research, the leading business intelligence provider, has released its latest
research, Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from
Traditional Mass-Media Platforms towards Personalization via Online and Social
Media, which provides insights into the up-and-coming trends of DTC
advertising in the US and of awareness campaigns in
Europe
. The report
provides an in-depth analysis of the types of marketing channels available to
pharmaceutical marketers. In particular it focuses on how pharmaceutical
marketers can make the most of digital media channels, including online
advertising and social media.
To Browse Full TOC, Tables & Figures
visit:
http://www.researchmoz.us/direct-to-consumer-dtc-advertising-
in-pharmaceuticals-shift-from-traditional-mass-media-platforms-
towards-personalization-via-online-and-social-media-report.html
The report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GBI
Researchs team of industry experts.
In 2006, over
$5 billion
was spent on DTC advertising, most of it on the most
expensive medium, television. Since then, DTC expenditure has decreased. This
is due to a number of reasons, notably the emergence of new media for
advertising. Since advertising moved onto the internet, there have been many
developments which have revolutionized the way that products are promoted.
Pharmaceutical companies were slow to move their advertising online but are
now beginning to use it to their advantage. The internet has proven itself to be
one of the most cost-effective forms of advertising; full campaigns can be run
for the price of one television advertisement.
Social media is another risky yet rewarding method of promotion that
pharmaceutical companies are beginning to explore. Through social media,
consumers expect to be able to have a public conversation with the
representatives of a brand; consumers will always expect their questions to be
answered and will not hesitate to discuss adverse effects and any other
problems that they consider to be the fault of a brand. However, through social
media, pharmaceutical companies have an opportunity to improve their brand
image through their responses to these enquires. Another huge advantage of
social media is the sharing between friends and peer groups that it enables. A
recommendation from a friend is trusted by 90% of people and 70% trust
consumer opinions posted online (Google, 2011), so campaigns that are spread
between friends by word of mouth can be more effective than traditional
methods of widely broadcast DTC.
Scope
- Data and analysis of traditional media channels and newer channels such as
online and mobile platforms.
- Suggestions of how the ROI (return on investment) of a social media
campaign can be measured.
- How to target a campaign to appropriate audiences by altering the media
mix.
- Examples of successful and violative campaigns.
- Examples of pioneering use of online media channels.
- How DTC advertising techniques can be transferred to unbranded campaigns
in countries where DTC is not permitted.
Reasons to buy
- Understand how DTC advertising has changed over the last decade.
- Develop the use of new media types such as social media and mobile.
- Create a more tailored advertising campaign designed to reach a targeted
audience.
- Develop key strategic initiatives by understanding the way that patients use
different media.
- Accelerate the delivery of marketing messages through word-of-mouth
communication.
Report Category: Pharmaceutical
Browse All
GBI Research Latest Reports & Industry Analysis
Latest Reports by GBI Research
Active Pharmaceutical Ingredients (API) Market in Europe
Direct to Consumer (DTC) Advertising in Pharmaceuticals
Multi-Targeted Therapies
Biobetters in Key Markets
Protein and Peptide-based Therapeutics
Biobanks - 2012 Year Book
Biosimilars in Developed Countries
Pharmaceutical Pricing and Reimbursement in Oncology
Novel Therapies in Oncology
Pharmaceutical Supply Chain in Europe
Major Power Markets in Eastern Europe to 2020
About Us
ResearchMoz is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across
industry verticals with our huge collection of market research reports. We
provide our services to all sizes of organizations and across all industry verticals
and markets. Our Research Coordinators have in-depth knowledge of reports
as well as publishers and will assist you in making an informed decision by
giving you unbiased and deep insights on which reports will satisfy your needs
at the best price.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY
12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-997-4948
Email:
sales@
researchmoz
.com
http://www.researchmoz.us/ http://marketresearchinsights.blogspot.de/